PATENT CLAIM ANALYSIS

Application Number: 15760029
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "003400"]

Abstract:
The disclosure relates to methods of treating a fungal infection in a subject by administering to the subject a salt of Compound 1, or a neutral form thereof. The methods of the disclosure can be useful in subjects suffering from treatment resistant infections, useful in subjects who have previously failed treatment with an anti-fungal therapy, and useful for suppressing the emergence of resistant strains in infected subjects.

Claim (Index 35):
The method of  claim 34 , wherein the method consists of\n (a) intravenously administering a first dose of about 400 mg of Compound 1 in salt or neutral form, (b) intravenously administering a second dose of about 400 mg of Compound 1 in salt or neutral form, and (c) optionally intravenously administering a third dose of about 400 mg of Compound 1 in salt or neutral form, wherein the first dose is administered on day 1, the second dose is administered on day 8, and the third dose, if administered, is administered on day 15.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 90.0
- Lexical Diversity: 1.53191
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14776398', '15371333', '16067713', '10895492', '14386266']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7963443758040424
- 35 USC 102 Novelty (BERT): 0.5228344682486716
- Combined Prediction Score: 0.7689933850485053
- Mean Citation Score: 302.6161160000001
- Max Citation Score: 314.2242
- Similarity Product: 203.94264624080657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test